SmarterDividends
NONOF

Novo Nordisk A/S

NONOF

Healthcare · Stock · semiannual payer

$49.70

Undervalued · +47% Add to Portfolio

Forward Yield

3.71%

Annual Dividend

$1.81

Payout Ratio

43%

5-Yr Growth

28.5%

Ex-Date

Mar 27, 2026

Frequency

Semiannual

Summary

As of July 2026, Novo Nordisk A/S (NONOF) yields 3.71% ($1.81 per share annually), with a blended fair-value estimate of $73.27 — +47% upside, so it screens as undervalued. Dividend safety grade: C (55/100). 6 years of dividend growth.

Is NONOF a good dividend stock?

Mixed

Novo Nordisk A/S (NONOF) pays a semiannual dividend yielding 3.71% ($1.81/yr), with 6 years of growth and a dividend-safety grade of C. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Advantages

  • Comfortable payout ratio (43%)
  • Strong 28.5% 5-yr dividend growth

Risks

  • Cut its dividend in 2017
  • Share price is down over the past 5 years

Key Data

Dividend Yield
3.71%
Payout Ratio
43%
Annual Dividend
$1.81
5-Yr Avg Growth
28.5%
Ex-Dividend Date
Mar 27, 2026
Years of Growth
6
Frequency
semiannual
Beta
0.36
Market Cap
$219.8B
P/E Ratio
11.9
5-Yr Total Return
-2%
52-Week Range
$34.00 – $72.21
Dividend Safety
C · 55/100
Ever Cut?
Yes (2017)
NONOF ex-dividend date & scheduleNext ex-date Mar 27, 2026 · full ex-dividend historyView →

Frequently Asked Questions

Income Calculator

At $1.81 / yr per share

Per payment (semiannual)$90.50
Annual$181.00
Monthly avg$15.08